Award
National Heart, Lung, and Blood Institute 5R01HL160437-04
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
Recipient
Not Specified
Award Amount
$513,760.00
Ceiling
$513,760.00
Awarded
August 19, 2024
Identifier
5R01HL160437-04
NIH/NHLBI awarded a research grant to study heart failure with preserved ejection fraction among persons with HIV in South Africa, focusing on clinical and immunologic factors, with a total budget of $513,760 for 2024-2026.
Description
This project is funded by the NIH/NHLBI under grant number 5R01HL160437-04. It focuses on research related to heart failure with preserved ejection fraction among persons living with HIV in South Africa. The project involves clinical and biologic studies, including echocardiography and cardiac magnetic resonance imaging, to understand the prevalence, phenogroups, and immunologic factors associated with HFpEF in this population. The award is for a multi-year period from September 2024 to August 2026, with a total budget of approximately $513,760.